SERALITE® - FLC SERUM

RAPID UNIT TEST FOR sFLC κ/λ QUANTITATIVE MEASUREMENT

Test presentation

SERALITE® - FLC SERUM kit allows the simultaneous measurement of kappa and lambda free light chains (FLC) in human serum. SERALITE® - FLC SERUM antibodies yield a high degree of sensitivity and specificity as shown by their extensive validation with more than 14000 patient samplesa.

The reading and ratio calculation are automatically performed by the “all in one” ADxLR5 reader.

Test principle

SERALITE® - FLC SERUM is a lateral flow immunoassay based on competitive inhibition.
The operator will mix 100 µL of patient serum within a single vial of the ready to use application buffer. 100 µL of the mix is applied onto the device. After 10 min of incubation, results are read in the ADxLR5 to simultaneously obtain free kappa and free lambda concentration in mg/L and κ/λ ratio calculation.

SERALITE® - FLC SERUM in conjunction with the ADxLR5 uses an integrated calibration mode with no need to calibrate each batch of tests.

free light chain assay 

Performances

  • Broad measurement rangeb,c: 2.5 - 200 mg/L
  • Excellent precisionb,c: <10%
  • Antigen excess freeb,c
  • Positive ID
  • Single test and batch mode (up to 10 samples)
  • One result in 10 minutes
  • Data transfer to LIS: Results can either be automatically transferred to the LIS via the Sebia Phoresis software or in direct connection to LIS

 

Kit description

SERALITE® - FLC SERUM, 25 tests (PN 5200)

Kit content:

  • Seralite® - FLC devices
  • Application Buffer
  • Dilution Buffer

Related products and accessories:

  • Seralite® - FLC QC device (PN 5150)
  • Dual Kappa and Lambda FLC controls (PN 5210)

 

 

 

Compatible Instruments

ADxLR5 reader (PN 5010)

Publications

a Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine. Campbell J.P. et al, J of Immunol Methods. 2013; 391:1-13

b Measurement of free light chains with assays based on monoclonal antibodies. Te Velthuis H. et al., Clin Chem Lab Med. 2016

c Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool. Campbell J.P. et al, Clin Chem Lab Med. 2016

d Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests. Heaney, J. L. et al, Br J Haematol. 2017

e Multiple myeloma can be accurately diagnosed in acute kidney injury patients using a rapid serum free light chain test. Heaney et al. BMC Nephrology 2017

Commercial information

SERALITE® - FLC SERUM is a product of Abingdon Health

Abingdon Health
National Agri-food Innovation Campus
Sand Hutton, York, YO41 1LZ
United Kingdom
Tel. : +44 (0) 1904 406 080
e-mail : info@abingdonhealth.com  

SERALITE® - FLC SERUM is distributed worldwide except in Benelux by Sebia

SEBIA
Parc Technologique Léonard de Vinci
27 rue Léonard de Vinci
CP 8010 Lisses, 91008 EVRY Cedex
France
Tel. : +33 (0)1 69 89 80 80
Fax : +33 (0)1 69 89 78 78
e-mail : sebia@sebia.com